[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Medicines, Ethics and Practice Edition 46 – July 2023

Medicines, Ethics and Practice Edition 46 – July 2023

by Steven Hewison | Jul 31, 2023 | Blog

The Royal Pharmaceutical Society have just released Medicines, Ethics and Practice Edition 46 – July 2023.

Brief reflections on a Licence Based Inspection

Brief reflections on a Licence Based Inspection

by John Finey | Jul 28, 2023 | Blog, MHRA

Phew…..that was exhausting!!! I know that is a usual comment after an inspection but this was a two day (and two inspectors, a lead inspector plus a trainee) under the new Licence Based Inspection process.

Donanemab – the latest dementia break through drug

Donanemab – the latest dementia break through drug

by Amelia Holmes | Jul 25, 2023 | Blog

If you have been keeping an eye on the news lately Donanemab will not be a new name to you. Donanemab is the latest break through drug for the treatment of Alzheimer’s.

The Challenge of 100-Hour Pharmacies

The Challenge of 100-Hour Pharmacies

by Sally Cox | Jun 14, 2023 | Blog, Pharmacy

On May 25 this year, the NHS terms of service were amended, allowing 100-hour pharmacies to reduce their opening hours from 100 to 72 hours.

BREAKING: Scottish government provides £20m pharmacy ‘interim cash injection’

BREAKING: Scottish government provides £20m pharmacy ‘interim cash injection’

by John Finey | Jun 5, 2023 | Blog, Pharmacy

Does this mean that Scottish pharmacies have hit the jackpot!?! Well, of course not, this is to ‘ease pressures’ currently faced by pharmacies, and numbers can be very misleading.

MHRA new recognition routes to access to new medicines

MHRA new recognition routes to access to new medicines

by Steven Hewison | Jun 5, 2023 | Blog, Brexit, MHRA

After Brexit the MHRA had been preparing to take over the role of sole approver of newly licensed medicines in the UK until now.

« Older Entries
Next Entries »

Recent Posts

  • UK Confirms Indefinite Recognition of CE-Marked Medical Devices
  • Minister responsible for Pharmacy announced
  • Heatwaves, Medicines and the Leadership Imperative

Upcoming Courses

  • Superintendent Pharmacist training (Online) on 25 November 2026
  • RP Forum – tbc on 1 December 2026 10:00 am
  • GDP Audit Online Training on 7 December 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 8 December 2026 10:00 am
  • Export Online Training on 9 December 2026 10:00 am

MHRA Alerts & Recalls

Field Safety Notices: 9 to 13 November 2026
17 November 2026
Class 4 Medicines Defect Notification: Star Pharmaceuticals Ltd, Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets, EL(26)A/48
12 November 2026
Field Safety Notices: 2 to 6 November 2026
10 November 2026
Class 4 Medicines Defect Notification: Sandoz Limited, Co-Amoxiclav powder for oral suspension 250/62.5 mg/5mL, EL(26)A/46
5 November 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow